FDA Is Said to Clear Updated COVID Shots as Early as Next Week
Pfizer, BioNTech Hit Roadblock in COVID-flu Vaccine Trial
Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study
The only manufacturer of smallpox vaccine has submitted clinical data and plans to expand the scope of vaccination.
Bavarian Nordic announced that it has submitted clinical data to the European Medicines Agency to seek an expansion of the indication for its Imvanex vaccine to adolescents aged 12-17. Yesterday, Sweden, the neighboring country of Denmark, reported the first confirmed case of monkeypox, which is also the first case confirmed outside the African continent since this epidemic outbreak.
Goldman Sachs lowered the target price for Moderna to $88.
JPMorgan has lowered Moderna's target price from $96 to $88 and maintains a "neutral" rating.
Pfizer and Moderna Covid-19 Vaccines Usage and Updated Safety Labels
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
